Literature DB >> 20225020

Mitochondrial diseases: a cross-talk between mitochondrial and nuclear genomes.

Antonella Spinazzola1, Massimo Zeviani.   

Abstract

More than one billion years ago, mitochondria were free-living prokaryotic organisms with their own DNA. However, during the evolution, ancestral genes have been transferred from the mitochondrial to the nuclear genome so that mtDNA became dependent on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause Mendelian diseases that affect mtDNA integrity or expression.

Entities:  

Mesh:

Year:  2009        PMID: 20225020     DOI: 10.1007/978-90-481-2813-6_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

Review 1.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

2.  MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions.

Authors:  Caterina Garone; Juan Carlos Rubio; Sarah E Calvo; Ali Naini; Kurenai Tanji; Salvatore Dimauro; Vamsi K Mootha; Michio Hirano
Journal:  Arch Neurol       Date:  2012-12

3.  p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA.

Authors:  Elad Bonda; Galia Rahav; Angelina Kaya; Mary Bakhanashvili
Journal:  Oncotarget       Date:  2016-11-08

Review 4.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 5.  Genes and Pathways Involved in Adult Onset Disorders Featuring Muscle Mitochondrial DNA Instability.

Authors:  Naghia Ahmed; Dario Ronchi; Giacomo Pietro Comi
Journal:  Int J Mol Sci       Date:  2015-08-05       Impact factor: 5.923

6.  Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease.

Authors:  Francesco Bruni; Ivano Di Meo; Emanuele Bellacchio; Bryn D Webb; Robert McFarland; Zofia M A Chrzanowska-Lightowlers; Langping He; Ewa Skorupa; Isabella Moroni; Anna Ardissone; Anna Walczak; Henna Tyynismaa; Pirjo Isohanni; Hanna Mandel; Holger Prokisch; Tobias Haack; Penelope E Bonnen; Bertini Enrico; Ewa Pronicka; Daniele Ghezzi; Robert W Taylor; Daria Diodato
Journal:  Hum Mutat       Date:  2018-02-07       Impact factor: 4.878

7.  Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.

Authors:  Caterina Garone; Beatriz Garcia-Diaz; Valentina Emmanuele; Luis C Lopez; Saba Tadesse; Hasan O Akman; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  EMBO Mol Med       Date:  2014-08       Impact factor: 12.137

Review 8.  Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi.

Authors:  Surbhi Verma; Viplendra P S Shakya; Alexander Idnurm
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

9.  Loss of the Mia40a oxidoreductase leads to hepato-pancreatic insufficiency in zebrafish.

Authors:  Anna M Sokol; Barbara Uszczynska-Ratajczak; Michelle M Collins; Michal Bazala; Ulrike Topf; Pia R Lundegaard; Sreedevi Sugunan; Stefan Guenther; Carsten Kuenne; Johannes Graumann; Sherine S L Chan; Didier Y R Stainier; Agnieszka Chacinska
Journal:  PLoS Genet       Date:  2018-11-20       Impact factor: 5.917

10.  A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family.

Authors:  Keze Ma; Mingyu Xie; Xiaoguang He; Guojun Liu; Xiaomei Lu; Qi Peng; Baimao Zhong; Ning Li
Journal:  BMC Med Genet       Date:  2018-11-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.